4.3 Review

B cells and antibodies in CNS demyelinating disease

Journal

JOURNAL OF NEUROIMMUNOLOGY
Volume 112, Issue 1-2, Pages 1-14

Publisher

ELSEVIER
DOI: 10.1016/S0165-5728(00)00409-4

Keywords

multiple sclerosis; experimental autoimmune encephalomyelitis; B cell; plasma cell; antibody

Ask authors/readers for more resources

There is much evidence to implicate B cells, plasma cells, and their products in the pathogenesis of MS. Despite unequivocal evidence that the animal model for MS, EAE, is initiated by myelin-specific T cells, there is accumulating evidence of a role for B cells, plasma cells, and their products in EAE pathogenesis. The role(s) played by B cells, plasma cells, and antibodies in CNS inflammatory demyelinating diseases are likely to be multifactorial and complex, involving distinct and perhaps opposing roles for B cells versus antibody. (C) 2001 Elsevier Science B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available